Search | Page 4 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Efficacy, safety, and pharmacokinetics of subcutaneous azacitidine in Taiwanese patients with higher-risk myelodysplastic syndromes

    ... transfusion independence and 7 of 18 attained platelet transfusion independence. Most common grade 3-4 treatment-emergent ...

    Research Article last updated 02/03/2017 - 10:05am.

  2. Clinical applications of haploidentical hematopoietic stem cell transplantation in severe aplastic anemia

    ... (ANC) > 0.5×109/L, and the average time of 15.0d for platelet count was more than 20×109/L. Follow-up for 1 month later ...

    Research Article last updated 02/03/2017 - 9:36am.

  3. Denise Beauchemin - My Life is Making a Difference

    ... last red cell transfusion and by early June had my last platelet transfusion . One side effect of treatment with cyclosporine is ...

    Patient Chronicle last updated 04/12/2017 - 7:12am.

  4. Left main crossover stenting in a patient with severe thrombocytopenia due to aplastic anemia

    ... because of severe thrombocytopenia and anemia ( platelet 11 × 103/μL, hemoglobin 6.4 g/dL). Refractory ...

    Research Article last updated 12/09/2016 - 2:08pm.

  5. Alternative Donor Transplantation with High-Dose Post-Transplantation Cyclophosphamide for Refractory Severe Aplastic Anemia

    ... was 25 (range, 2 to 58) days, and to last platelet transfusion to keep platelets counts over 50 × 103/mm3 was ...

    Research Article last updated 01/24/2017 - 10:04am.

  6. Interim analysis of post-marketing surveillance of eculizumab for paroxysmal nocturnal hemoglobinuria in Japan

    ... were observed, especially in patients with platelet count ≥150 × 109/L. Approximately 97 % of patients showed ...

    Research Article last updated 11/02/2016 - 10:39am.

  7. Strong results for SAA patients at Johns Hopkins

    ... of the patients' red and white blood cell and platelet counts had returned to normal levels without the need for blood ...

    Article last updated 02/07/2017 - 11:05am.

  8. Design and rationale of the QUAZAR Lower-Risk MDS (AZA-MDS-003) trial: a randomized phase 3 study of CC-486 (oral azacitidine) plus best supportive care vs placebo plus best supportive care in patients with IPSS lower-risk myelodysplastic syndromes and po

    ... who may have required red blood cell or platelet transfusions. The overall response rate was 40 %, including ... include overall survival, hematologic response including platelet response and erythroid response, RBC transfusion independence ...

    Research Article last updated 06/23/2016 - 10:17am.

  9. My Son, the Athlete and Survivor

    ... romiplostim, but during the tapering phase his platelet count took a small jump up to 63,000. While continuing to taper, ... and basketball. Needless to say, his diagnosis and the low platelet counts have left him sitting on the bench doing stats or assistant ...

    Patient Chronicle last updated 12/14/2016 - 1:53pm.

  10. Red Blood Cell Transfusion Dependency and Hyperferritinemia Are Associated with Impaired Survival in Patients Diagnosed with Myelodysplastic Syndromes: Results from the First Polish MDS-PALG Registry

    ... RBC-transfusion dependence (p = 0.0033; HR 2.67L), platelet transfusion dependence (p = 0.0071; HR 3.321), hemoglobin ... concentration higher than 1000 ng/L (p = 0.0023; HR = 2.94), platelet count lower than 10 G/L (p = 0.0081 HR = 5.04), acute leukemia ...

    Research Article last updated 10/06/2016 - 1:01pm.